X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (25) 25
humans (23) 23
male (23) 23
adult (17) 17
female (17) 17
gastroenterology & hepatology (17) 17
middle aged (15) 15
antiviral agents - therapeutic use (11) 11
genotype (10) 10
hepatitis (9) 9
hepatitis c (9) 9
aged (8) 8
diseases of the digestive system. gastroenterology (8) 8
hepacivirus - genetics (8) 8
hepatitis c, chronic - drug therapy (8) 8
treatment outcome (7) 7
viral load (7) 7
abridged index medicus (6) 6
antiviral agents - adverse effects (6) 6
interferon-alpha - therapeutic use (6) 6
aged, 80 and over (5) 5
alanine transaminase - blood (5) 5
antiviral agents - administration & dosage (5) 5
cirrhosis (5) 5
gastroenterology and hepatology (5) 5
interferon-alpha - adverse effects (5) 5
liver (5) 5
natural-history (5) 5
original (5) 5
recombinant proteins (5) 5
ribavirin - therapeutic use (5) 5
therapy (5) 5
adolescent (4) 4
animals (4) 4
drug therapy, combination (4) 4
interferon (4) 4
interferon-alpha - administration & dosage (4) 4
liver disease (4) 4
original article (4) 4
rna, viral - blood (4) 4
studies (4) 4
virus-infection (4) 4
young adult (4) 4
fusion protein (3) 3
hepacivirus - drug effects (3) 3
hepatitis b virus - genetics (3) 3
hepatitis b, chronic - virology (3) 3
hepatitis c - drug therapy (3) 3
hepatitis c virus (3) 3
hepatitis c, chronic - virology (3) 3
hepatocellular carcinoma (3) 3
hepatocellular-carcinoma (3) 3
injections, subcutaneous (3) 3
medicine, general & internal (3) 3
mutation (3) 3
outcomes (3) 3
polyethylene glycols - therapeutic use (3) 3
rats (3) 3
rats, sprague-dawley (3) 3
recombinant proteins - adverse effects (3) 3
retrospective studies (3) 3
ribavirin - adverse effects (3) 3
risk factors (3) 3
time factors (3) 3
virology (3) 3
virus (3) 3
adefovir dipivoxil (2) 2
adenine - analogs & derivatives (2) 2
adenine - therapeutic use (2) 2
administration, oral (2) 2
age factors (2) 2
albumin-interferon alfa (2) 2
antiviral agents (2) 2
biochemistry, general (2) 2
biological response modifiers (2) 2
canada (2) 2
care and treatment (2) 2
chronic hepatitis-c (2) 2
clinical trials (2) 2
dna - biosynthesis (2) 2
dna, viral - blood (2) 2
dose-response relationship, drug (2) 2
drug administration schedule (2) 2
drug resistance, viral (2) 2
drug therapy (2) 2
epidemiology (2) 2
fatty liver (2) 2
follow-up (2) 2
gastroenterology (2) 2
genetic aspects (2) 2
genome (2) 2
genotypes (2) 2
health aspects (2) 2
hepatitis b (2) 2
hepatitis b core antigens - genetics (2) 2
hepatitis b virus - isolation & purification (2) 2
hepatitis b, chronic - drug therapy (2) 2
hepatitis b, chronic - pathology (2) 2
hepatology (2) 2
infection (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Physical Review Letters, ISSN 0031-9007, 08/2009, Volume 103, Issue 7, pp. 075001 - 075001
Reduction or elimination of edge localized modes (ELMs) while maintaining high confinement is essential for future fusion devices, e.g., the ITER. An ELM-free... 
NSTX PLASMAS | COLLISIONALITY REGIME | PHYSICS, MULTIDISCIPLINARY | OPERATION | STABILITY | CONFINEMENT | DIII-D TOKAMAK | PEDESTAL | PHYSICS | HIGH-BETA | GAS FUELING LOCATION
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2008, Volume 359, Issue 23, pp. 2442 - 2455
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2018, Volume 378, Issue 4, pp. 354 - 369
Journal Article
Gastroenterology, ISSN 0016-5085, 05/2018, Volume 154, Issue 6, pp. S-1168 - S-1168
Journal Article
Gastroenterology, ISSN 0016-5085, 2011, Volume 140, Issue 1, pp. 132 - 143
Journal Article
Liver international : official journal of the International Association for the Study of the Liver, ISSN 1478-3223, 05/2019
Tenofovir disoproxil fumarate (TDF) is a first-line treatment for chronic hepatitis B (CHB). We aimed to describe the efficacy and safety profiles of TDF... 
Journal Article
Hepatology, ISSN 0270-9139, 08/2008, Volume 48, Issue 2, pp. 407 - 417
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2006, Volume 44, Issue 4, pp. 671 - 678
: Recombinant human albumin-interferon alfa (alb-IFN) is a novel 85.7-kD recombinant protein consisting of interferon alfa-2b genetically fused to human serum... 
Genotype 1 | Albumin-interferon alfa | Chronic hepatitis C | Viral kinetics | Pharmacokinetics | albumin-interferon alfa | PLUS RIBAVIRIN | THERAPY | VIRUS | chronic hepatitis C | pharmacokinetics | genotype 1 | viral kinetics | GASTROENTEROLOGY & HEPATOLOGY | Humans | Middle Aged | Serum Albumin - administration & dosage | Half-Life | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Recombinant Proteins - pharmacokinetics | Fatigue - chemically induced | Recombinant Proteins - adverse effects | Arthralgia - chemically induced | Serum Albumin, Human | Serum Albumin - adverse effects | Dose-Response Relationship, Drug | Chills - chemically induced | Injections, Subcutaneous | Interferon-alpha - pharmacokinetics | Adult | Female | Headache - chemically induced | Serum Albumin - pharmacokinetics | Drug Tolerance | RNA, Viral - analysis | Genotype | Hepatitis C, Chronic - drug therapy | Recombinant Proteins - administration & dosage | Interferon-alpha - administration & dosage | Interferon-alpha - adverse effects | Hepatitis C, Chronic - genetics | Antiviral agents | Safety and security measures | RNA | Fatigue testing machines | Materials | Clinical trials | Antiship missiles | Fatigue | Serum albumin | Biological response modifiers | Recombinant proteins | Genetic aspects | Universities and colleges | Hepatitis C | Health aspects | Index Medicus
Journal Article
Canadian Journal of Gastroenterology and Hepatology, ISSN 2291-2789, 2014, Volume 28, Issue 5, pp. 243 - 250
Although the exact prevalence of hepatitis C virus (HCV) infection in Canada is unknown, previous studies and anecdotal evidence suggest that the burden of HCV... 
Cirrhosis | Hepatocellular carcinoma | Hepatitis C | Outcomes; treatment | Mortality | Studies | Hepatitis | Health care expenditures | Liver diseases | Treatment | Original | Outcomes
Journal Article